A carregar...
Safety of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Pregnancy: Review of Non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006 – 2013
BACKGROUND: In 2006, quadrivalent human papillomavirus (HPV4; Gardasil, Merck & Co. Inc.) vaccine was licensed in the US for use in females aged 9 to 26 years. HPV4 is not recommended during pregnancy; however, inadvertent administration during pregnancy may occur. OBJECTIVES: To evaluate and su...
Na minha lista:
| Publicado no: | Vaccine |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524774/ https://ncbi.nlm.nih.gov/pubmed/25500173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.11.047 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|